NOGO-66 receptor deficient mice show slow acquisition of spatial memory task performance

Neuroscience Letters

Volumn 510, Issue 1, 2012, Pages 58-61

  Van Gaalen, Marcel M ^a   Relo, Ana L ^a   Mueller, Bernhard K ^a   Gross, Gerhard ^a   Mezler, Mario ^a  

^a ABBOTT GMBH AND CO KG   (Germany)

Author keywords

Cognition; Knock out; Learning; Memory; NgR1; Schizophrenia

Indexed keywords

AMPHETAMINE; NOGO 66 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; BODY WEIGHT; COGNITION; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GENE DELETION; GENOTYPE; HYPERACTIVITY; HYPERTHERMIA; HYPOPHAGIA; IMMOBILIZATION STRESS; LATENT PERIOD; LOCOMOTION; MALE; MOUSE; NONHUMAN; POSITIVE SYNDROME; PRIORITY JOURNAL; SCHIZOPHRENIA; SPATIAL MEMORY; TASK PERFORMANCE; TEMPERATURE STRESS;

ALZHEIMER DISEASE; AMPHETAMINE; ANIMALS; EATING; FEMALE; FEVER; HYPERKINESIS; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED C57BL; MYELIN PROTEINS; NEURONAL PLASTICITY; PHENCYCLIDINE; RESTRAINT, PHYSICAL; SCHIZOPHRENIA; TIME FACTORS;

EID: 84856525430     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.01.004     Document Type: Article

References (19)

1. Arolfo M.P., Brioni J.D. Diazepam impairs place learning in the Morris water maze. Behav. Neural Biol. 1991, 55:131-136.
2. Budel S., Padukkavidana T., Liu B.P., Feng Z., Hu F., Johnson S., Lauren J., Park J.H., McGee A.W., Liao J., Stillman A., Kim J.E., Yang B.Z., Sodi S., Gelernter J., Zhao H., Hisama F., Arnsten A.F., Strittmatter S.M. Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J. Neurosci. 2008, 28:13161-13172.
3. Delekate A., Zagrebelsky M., Kramer S., Schwab M.E., Korte M. NogoA restricts synaptic plasticity in the adult hippocampus on a fast time scale. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:2569-2574.
4. Driscoll D.A., Spinner N.B., Budarf M.L., Donald-McGinn D.M., Zackai E.H., Goldberg R.B., Shprintzen R.J., Saal H.M., Zonana J., Jones M.C. Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome. Am. J. Med Genet. 1992, 44:261-268.
5. Gothelf D. Velocardiofacial syndrome Child Adolesc. Psychiatr. Clin. N. Am. 2007, 16:677-693.
6. GrandPre T., Li S., Strittmatter S.M. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 2002, 417:547-551.
7. Heinrichs S.C., Stenzel-Poore M.P., Gold L.H., Battenberg E., Bloom F.E., Koob G.F., Vale W.W., Pich E.M. Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor. Neuroscience 1996, 74:303-311.
8. Hsu R., Woodroffe A., Lai W.S., Cook M.N., Mukai J., Dunning J.P., Swanson D.J., Roos J.L., Abecasis G.R., Karayiorgou M., Gogos J.A. Nogo Receptor 1 (RTN4R) as a candidate gene for schizophrenia: analysis using human and mouse genetic approaches. PLoS 2007, 2:e1234.
9. Karlen A., Karlsson T.E., Mattsson A., Lundströmer K., Codeluppi S., Pham T.M., Bäckman C.M., Ogren S.O., Aberg E., Hoffman A.F., Sherling M.A., Lupica C.R., Hoffer B.J., Spenger C., Josephson A., Brene S., Olson L. Nogo receptor 1 regulates formation of lasting memories. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:20476-20481.
10. Kim J.E., Liu B.P., Park J.H., Strittmatter S.M. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron 2004, 44:439-451.
11. Lee H., Raiker S.J., Venkatesh K., Geary R., Robak L.A., Zhang Y., Yeh H.H., Shrager P., Giger R.J. Synaptic function for the Nogo-66 receptor NgR1: regulation of dendritic spine morphology and activity-dependent synaptic strength. J. Neurosci. 2008, 28:2753-2765.
12. Li S., Liu B.P., Budel S., Li M., Ji B., Walus L., Li W., Jirik A., Rabacchi S., Choi E., Worley D., Sah D.W., Pepinsky B., Lee D., Relton J., Strittmatter S.M. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J. Neurosci. 2004, 24:10511-10520.
13. Liu H., Abecasis G.R., Heath S.C., Knowles A., Demars S., Chen Y.J., Roos J.L., Rapoport J.L., Gogos J.A., Karayiorgou M. Genetic variation in the 22q11 locus and susceptibility to schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:16859-16864.
14. McNamara R.K., Skelton R.W. Assessment of a cholinergic contribution to chlordiazepoxide-induced deficits of place learning in the Morris water maze. Pharmacol. Biochem. Behav. 1992, 41:529-538.
15. Meng J., Shi Y., Zhao X., Guo S., Wang H., Zheng Y., Tang R., Feng G., Gu N., Liu H., Zhu S., He L. No association between the genetic polymorphisms in the RTN4R gene and schizophrenia in the Chinese population. J. Neural Transm. 2007, 114:249-254.
16. Park J.H., Gimbel D.A., GrandPre T., Lee J.K., Kim J.E., Li W., Lee D.H., Strittmatter S.M. Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition. J. Neurosci. 2006, 26:1386-1395.
17. Sinibaldi L., De Luca A., Bellacchio E., Conti E., Pasini A., Paloscia C., Spalletta G., Caltagirone C., Pizzuti A., Dallapiccola B. Mutations of the Nogo-66 receptor (RTN4R) gene in schizophrenia. Hum. Mutat. 2004, 24:534-535.
18. Stenzel-Poore M.P., Heinrichs S.C., Rivest S., Koob G.F., Vale W.W. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J. Neurosci. 1994, 14:2579-2584.
19. Zheng B., Atwal J., Ho C., Case L., He X.L., Garcia K.C., Steward O., Tessier-Lavigne M. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:1205-1210.